Aquatic Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52K Buy
+1,394
New +$42.7K ﹤0.01% 1150
2025
Q3
– Sell
-85,178
Closed -$1.79M – 1523
2025
Q2
$1.79M Buy
85,178
+36,551
+75% +$701K 0.04% 498
2025
Q1
$797K Sell
48,627
-42,562
-47% -$907K 0.02% 654
2024
Q4
$2.34M Buy
91,189
+29,189
+47% +$826K 0.06% 341
2024
Q3
$1.96M Buy
62,000
+60,100
+3,163% +$2.28M 0.05% 367
2024
Q2
$66.7K Buy
+1,900
New +$75.2K ﹤0.01% 969
2023
Q3
– Sell
-300
Closed -$7K – 1429
2023
Q2
$7K Buy
+300
New +$6.17K ﹤0.01% 1223

Other funds holding IDYA

Aquatic Capital Management's IDYA Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 1,394 shares worth $52K. The stake represents ﹤0.01% of the portfolio and ranks #1150 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in IDYA as recently as Q2 2025.

Aquatic Capital Management first reported a position in IDYA in Q2 2023 and has held it in 7 quarters since. The position peaked at $2.34M in Q4 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Aquatic Capital Management held 1,394 shares of IDEAYA Biosciences worth $52K as of Q2 2026.
  • IDEAYA Biosciences was a new Aquatic Capital Management position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #1150 holding.
  • Aquatic Capital Management first reported a position in IDEAYA Biosciences in Q2 2023 and has held it in 7 quarters since.
  • Aquatic Capital Management's IDEAYA Biosciences position peaked at $2.34M in Q4 2024.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.